The first case of topical silver sulfadiazine-induced bcytopenia;Sulfadiazine argentique topique et bicytopénie: 1er cas

Therapie

Volumn 57, Issue 3, 2002, Pages 307-309

  Blangy, H ^a   Simon, D ^a   Levy Cloez A ^b   Feillet, F ^a   Fyad, J P ^b   Trechot P ^a   Gillet, P ^b   Lascombes, P ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HÔPITAL D ENFANTS   (France)

Author keywords

Bicytopenia; Leukopenia; Silver sulfadiazine

Indexed keywords

SULFADIAZINE SILVER;

ANTISEPSIS; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; LEUKOCYTE COUNT; LEUKOPENIA; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ANTI-INFECTIVE AGENTS, LOCAL; FATAL OUTCOME; HUMANS; INFANT; MALE; NEUTROPENIA; SILVER SULFADIAZINE;

EID: 18344406555     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bégaud B, Evreux JC, Jouglard J, et al. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 1985; 40: 111-4
2. Solal-Céligny P, Bénichou C, Boivin P, et al. Critères d'imputation d'une cytopénie granuleuse ou plaquettaire à un médicament. Résultats de réunions de consensus. Nouv Rev Fr Hématol 1987; 29: 265-70
3. Valente P, Axelrod JL. Acute leukopenia associated with silver sulfadiazine therapy. J Trauma 1978; 18: 146-7
4. Kiker RG, Carvajal HF, Mlcak RP, et al. A controlled study of the effects of silver sulfadiazine on white blood cell counts in burned children. J Trauma 1977; 17: 835-6
5. Jarrett F, Ellerbe S, Demling R. Acute leukopenia during topical burn therapy with silver sulfadiazine. Am J Surg 1978; 135: 818-9
6. Chan CK, Jarrett F, Moylan JA. Acute leukopenia as an allergic reaction to silver sulfadiazine in burn patients. J Trauma 1976; 16: 395-6
7. Caffee HH, Bingham HG. Leukopenia and silver sulfadiazine. J Trauma 1982; 22: 586-7
8. Choban PS, Marshall WJ. Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. Am Surg 1987; 53: 515-7
9. Gbaanador GB, Policastro AJ, Durfee D, et al. Transient leukopenia associated with topical silver sulfadiazine in bum therapy. Nebr Med J 1987; 72: 83-5
10. Thomson PD, Moore NP, Rice TL, et al. Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent. J Bum Care Rehabil 1989; 10: 418-20
11. Lockhart SP, Rushworth A, Azmy AAF, et al. Topical silver sulphadiazine: side effects and urinary excretion. Bums 1983; 10: 9-12
12. Viala J, Simon L, Le Pommelet C, et al. Agranulocytose après application de sulfadiazine argentique chez un nourrisson de 2 mois. Arch Pédiatr 1997; 4: 1103-6
13. Eldad A, Neuman A, Weinberg A, Benmeir P, et al. Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient bum patient. Bums 1991; 17: 430-2
14. Maitre S, Jaber K, Perrot JL, et al. Elévation des taux sériques et urinaires d'argent au cours d'un traitement topique par sulfadiazine argentique (Flammazine®). Ann Dermatol Venereol 2002; 129: 217-9